Cargando…
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management
AL amyloidosis results from clonal production of immunoglobulin light chains, most commonly arising from a clonal plasma cell disorder. Once considered a nearly uniformly fatal disease, prognosis has improved markedly over the past 15 years, predominantly because of advances in light chain suppressi...
Autores principales: | Witteles, Ronald M., Liedtke, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352106/ https://www.ncbi.nlm.nih.gov/pubmed/34396169 http://dx.doi.org/10.1016/j.jaccao.2019.08.002 |
Ejemplares similares
-
COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies
por: Atri, Deepak, et al.
Publicado: (2020) -
AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review
por: Wechalekar, Ashutosh D., et al.
Publicado: (2022) -
Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021) -
Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management
por: Cohen, Jordana B., et al.
Publicado: (2019) -
AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
por: Bianchi, Giada, et al.
Publicado: (2021)